ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
150 hedge funds and large institutions have $373M invested in iTeos Therapeutics in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 43 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 100.13% → 100.16% (+0.03%)
30% less capital invested
Capital invested by funds: $537M → $373M (-$163M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
150
Holding in Top 10
1
Calls
$27M
Puts
$3.94M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$8.22M | |
| 3 | +$6.95M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$4.83M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$4.24M |
Top Sellers
| 1 | -$25M | |
| 2 | -$11.1M | |
| 3 | -$10.7M | |
| 4 |
Morgan Stanley
New York
|
-$8.97M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6M |